179 related articles for article (PubMed ID: 23217400)
21. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
[TBL] [Abstract][Full Text] [Related]
22. [The expression of macrophage migration inhibition factor in pulmonary tissues of smokers with or without chronic obstructive pulmonary disease].
She WB; Liu XS; Ni W; Chen SX; Xu YJ
Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):863-6. PubMed ID: 23291023
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
24. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
[TBL] [Abstract][Full Text] [Related]
25. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
26. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
27. [Expressions of and the effect of smoking on vascular endothelial growth factor and induced nitric oxide synthase in lung tissues of chronic obstructive pulmonary disease patients].
Huo JM; Chen JY; Kong YJ; Shi YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):573-6. PubMed ID: 17988548
[TBL] [Abstract][Full Text] [Related]
28. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
[TBL] [Abstract][Full Text] [Related]
29. [The expression and implications of human alpha-defensin 1-3 in serum and induced sputum in patients with chronic obstructive pulmonary disease].
Wang Z; Yao WZ; Xia GG; Sun DJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):410-3. PubMed ID: 19031798
[TBL] [Abstract][Full Text] [Related]
30. Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease.
Heijink IH; de Bruin HG; van den Berge M; Bennink LJ; Brandenburg SM; Gosens R; van Oosterhout AJ; Postma DS
Thorax; 2013 Aug; 68(8):709-16. PubMed ID: 23370438
[TBL] [Abstract][Full Text] [Related]
31. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
32. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
34. [Expression and significance of hypoxia-inducible factor-1α in patients with chronic obstructive pulmonary disease and smokers with normal lung function].
Tao H; Luo W; Pei H; Zhu S; Zhang M; Chen B; He J; Zhang M; Zhou R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):852-5. PubMed ID: 25108440
[TBL] [Abstract][Full Text] [Related]
35. Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease.
Tsoumakidou M; Tzanakis N; Chrysofakis G; Kyriakou D; Siafakas NM
Respir Med; 2005 May; 99(5):572-9. PubMed ID: 15823454
[TBL] [Abstract][Full Text] [Related]
36. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
37. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
38. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers.
Zhang J; Chu S; Zhong X; Lao Q; He Z; Liang Y
Int Immunopharmacol; 2013 Jan; 15(1):58-66. PubMed ID: 23127823
[TBL] [Abstract][Full Text] [Related]
40. Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
Ravi AK; Khurana S; Lemon J; Plumb J; Booth G; Healy L; Catley M; Vestbo J; Singh D
Respir Res; 2014 Sep; 15(1):103. PubMed ID: 25183374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
